Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -221.87%-295.08K | 58.43%-193.6K | -86.20%4.29K | 75.56%-4.06K | 65.50%-102.16K | 50.19%-91.68K | 70.86%-465.71K | 114.68%31.11K | 91.24%-16.61K | 0.02%-296.14K |
| Net income from continuing operations | 26.05%-111.68K | 46.47%-443.42K | -0.01%-134.05K | 49.33%-76.68K | 65.66%-81.67K | 50.51%-151.02K | 69.37%-828.33K | 74.90%-134.04K | 56.96%-151.33K | 4.72%-237.79K |
| Operating gains losses | -21,528.57%-15K | -124.86%-33.09K | 114.86%45.11K | -2,881,600.00%-28.82K | -164.20%-49.45K | -99.98%70 | -85.63%133.12K | -164.01%-303.57K | -100.00%1 | --77.04K |
| Depreciation and amortization | 0.00%15.75K | 0.00%63.01K | 0.00%15.75K | 221.08%50.57K | -221.05%-19.07K | -0.01%15.75K | 20.84%63.01K | -58.25%15.75K | 199.94%15.75K | 199.96%15.75K |
| Unrealized gains and losses of investment securities | --0 | ---- | ---- | --0 | 99.73%-70 | 102.75%8.05K | ---- | ---- | -70.83%18.99K | 93.75%-26.09K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Other non cashItems | -433.87%-8.56K | -261.62%-22.61K | -48,392.16%-24.73K | -639.47%-34.11K | 492.36%33.67K | 26.07%2.56K | -46.68%13.99K | -100.35%-51 | 34.30%6.32K | 12.87%5.68K |
| Change In working capital | -632.48%-175.6K | 59.01%242.52K | -26.64%110.2K | -16.98%80.25K | 114.83%19.09K | -4.04%32.98K | 253.91%152.51K | 40.13%150.21K | 599.83%96.66K | -496.38%-128.73K |
| -Change in receivables | -183.59%-14.14K | -99.90%10 | 2,698.17%15.31K | -207.90%-13.4K | 172.10%3.09K | -530.94%-4.99K | 45.20%9.84K | 252.90%547 | -18.87%12.42K | -122.44%-4.29K |
| -Change in prepaid assets | -1,134.89%-144.6K | 546.06%28.25K | 177.11%549 | -93.27%1.26K | 165.07%12.48K | 149.46%13.97K | -82.20%4.37K | 88.99%-712 | -13.43%18.66K | -234.27%-19.17K |
| -Change in payables and accrued expense | -170.29%-16.87K | 54.92%214.25K | -37.26%94.34K | 40.88%92.4K | 103.35%3.52K | -13.10%23.99K | 206.03%138.3K | 32.48%150.38K | 384.58%65.59K | -91.51%-105.27K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -221.87%-295.08K | 58.43%-193.6K | -84.72%4.29K | 35.41%-8.79K | 66.88%-97.43K | 50.73%-91.68K | 70.67%-465.71K | 113.93%28.11K | 92.82%-13.61K | 0.69%-294.14K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 427.65%27K | -58.84%90.22K | -97.15%5.12K | -53.22%219.18K | -54.52%218.51K | |||||
| Net investment purchase and sale | 427.65%27K | -58.84%90.22K | ---- | ---- | ---- | -97.15%5.12K | -53.22%219.18K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 427.65%27K | -58.84%90.22K | ---- | ---- | ---- | -97.15%5.12K | -53.22%219.18K | -54.52%218.51K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 744.80%690.63K | -68.51%72.92K | 54.96%-106.94K | -512.59%-18.48K | -75.83%116.59K | 556.55%81.75K | 84.77%231.55K | 13.40%-237.43K | -88.30%4.48K | 29.94%482.41K |
| Net issuance payments of debt | -1.88%-18.59K | -1.91%-73.58K | -1.90%-18.6K | -1.90%-18.48K | -1.92%-18.25K | -1.92%-18.25K | -12.87%-72.2K | -1.92%-18.25K | -0.97%-18.14K | 0.91%-17.91K |
| Net common stock issuance | 650.00%750K | -51.18%150K | --0 | --0 | -83.73%50K | --100K | 47.72%307.25K | ---1 | --0 | --307.25K |
| Net other financing activities | ---40.78K | 0.00%-3.5K | 59.69%-88.34K | --0 | ---- | ---- | 81.30%-3.5K | 14.48%-219.18K | -59.78%22.62K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 744.80%690.63K | -68.51%72.92K | 54.96%-106.94K | -512.50%-18.48K | -75.83%116.59K | 556.55%81.75K | 84.77%231.55K | 13.40%-237.43K | -88.29%4.48K | 29.94%482.41K |
| Net cash flow | ||||||||||
| Beginning cash position | --0 | -32.95%30.46K | -39.67%12.43K | 33.52%39.7K | 12.67%25.65K | -32.95%30.46K | -95.68%45.44K | -61.87%20.6K | -86.25%29.73K | -83.88%22.77K |
| Current changes in cash | 8,884.70%422.54K | -103.45%-30.46K | -226.05%-12.43K | -198.69%-27.27K | 101.68%14.05K | 78.78%-4.81K | 98.51%-14.97K | 214.64%9.86K | 94.37%-9.13K | -90.72%6.97K |
| End cash Position | 1,547.22%422.54K | --0 | --0 | -39.67%12.43K | 33.52%39.7K | 12.67%25.65K | -32.95%30.46K | -32.95%30.46K | -61.87%20.6K | -86.25%29.73K |
| Free cash from | -221.87%-295.08K | 58.43%-193.6K | -84.72%4.29K | 35.41%-8.79K | 66.88%-97.43K | 50.73%-91.68K | 70.67%-465.71K | 114.80%28.11K | 93.21%-13.61K | 0.69%-294.14K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.